Jpmorgan Chase & Co »

Nrx Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Nrx Pharmaceuticals shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Nrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Nrx Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nrx Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $83 34 2.44

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf (SPY)
Meta Platforms Common (META)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Vanguard Total Intl Bond Etf Fund (BNDX)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Nrx Pharmaceuticals

Vanguard Group
AdvisorShares Investments
Geode Capital Management
Susquehanna International
BlackRock
Citadel Advisors
Virtu Financial
State Street Corporation
One Wealth Management Investment & Advisory Services
Morgan Stanley
Royal Bank of Canada
Tower Research Capital
Bank of America Corporation
Wells Fargo & Company
Goss Wealth Management

View all funds holding Nrx Pharmaceuticals